Brain endopeptidase generates enkephalin from striatal precursors

An Enzyme capable of converting putative opioid peptide intermediates to free enkephalin has been purified 300-fold from washed rat brain membranes. The action of this Enzyme, an enkephalin-generating endopeptidase (EGE), was compared with the action of Carboxypeptidase B after trypsin treatment on enkephalin precursor Peptides present in rat striata. After Sephadex G-100 gel filtration of striatal material, fractions were radioimmunoassayed for enkephalin content using an antiserum specific for the carboxyl terminal of enkephalin. Additionally, aliquots of the column fractions were treated with either trypsin and Carboxypeptidase B, trypsin and EGE, or EGE alone. The peak of enkephalin immunoreactivity increased with the enzymes' treatment indicating the conversion of the low molecular weight proenkephalin precursor Peptides to enkephalin. Trypsin and EGE generated almost as much enkephalin as trypsin and Carboxypeptidase B in the conditions of the experiment. Thus EGE is capable of processing precursors to enkephalin after the action of trypsin-like Enzyme(s) in the brain. The gel filtration fractions containing enkephalin and its low molecular weight precursors were pooled and one-half treated with EGE. The contents were analyzed by HPLC and the increase in immunoreactivity co-eluted with enkephalin and Leu-enkephalin. Small Peptides found to be the most potent competitive inhibitors of this Enzyme are Met-Arg-Phe-Ala, and Met-Arg-Phe.